drugset

drugset / Trial / NCT00150293

Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

NCT00150293 ↗

Phase 3 Completed 337 enrolled Pfizer

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To determine long-term safety and efficacy of pregabalin in patients with partial seizures.

Timeline

Start: 2002-03
Primary completion: —
Completion: 2005-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pregabalin	Small molecule	—	—

Indications